The Meda Pharmaceutical Inc, the US subsidiary of Sweden-based Meda AB, has filed a patent infringement suit against Mumbai-based Sun Pharmaceuticals Ltd in the United States District Court for the District of Delaware on the latter's Para IV filing to market the generic antihistamine nasal spray product in US.
The details can be read here.
No comments:
Post a Comment